Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults

BACKGROUND: A vaccine would be an ideal tool for reducing malaria’s impact. PfSPZ Vaccine (radiation attenuated, aseptic, purified, cryopreserved Plasmodium falciparum [Pf] sporozoites [SPZ]) has been well tolerated and safe in >1526 malaria-naive and experienced 6-month to 65-year-olds in the Un...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Jongo, Said A, Church, L W Preston, Mtoro, Ali T, Schindler, Tobias, Chakravarty, Sumana, Ruben, Adam J, Swanson, Phillip A, Kassim, Kamaka R, Mpina, Maximillian, Tumbo, Anneth-Mwasi, Milando, Florence A, Qassim, Munira, Juma, Omar A, Bakari, Bakari M, Simon, Beatus, James, Eric R, Abebe, Yonas, KC, Natasha, Saverino, Elizabeth, Fink, Martina, Cosi, Glenda, Gondwe, Linda, Studer, Fabian, Styers, David, Seder, Robert A, Billingsley, Peter F, Daubenberger, Claudia, Sim, B Kim Lee, Tanner, Marcel, Richie, Thomas L, Abdulla, Salim, Hoffman, Stephen L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Major Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947995/
https://ncbi.nlm.nih.gov/pubmed/31782768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz1152
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia